Transrail Lighting Limited IPO...
19 Dec 2024
Suraksha Clinic and Diagnostic Limited IPO
Incorporated in 2005, Suraksha Diagnostic Limited has emerged as a leading provider of pathology, radiology testing, and medical consultancy services across India. The company boasts an extensive network, including a central reference laboratory supported by eight satellite laboratories and 215 customer touchpoints. This includes 49 state-of-the-art diagnostic centres and 166 strategically located sample collection centres, spanning the regions of West Bengal, Bihar, Assam, and Meghalaya as of June 30, 2024.
Suraksha Diagnostic Limited is committed to offering both online and offline medical consultation services, seamlessly integrated under one roof. They operate 44 advanced diagnostic centres that house 120 polyclinics, collaborating with a robust team of over 750 highly qualified doctors. This integrated approach ensures that patients receive comprehensive care from diagnosis to consultation, enhancing the overall healthcare experience.
The company’s operations are underpinned by cutting-edge technology platforms designed to streamline processes and enhance efficiency. Key systems include the Laboratory Information Management System (LIMS), a fully integrated Radiology Information System (RIS), the Picture Archive Communication System (PACS), and an Enterprise Resource Planning System (ERP). These systems enable seamless data management and efficient service delivery, ultimately benefiting patients and healthcare professionals alike.
In addition to diagnostic services, Suraksha Diagnostic Limited offers vaccination services and customized testing packages aimed at disease prediction and early detection. Utilizing digital pathology and artificial intelligence, the company generates accurate and timely blood tests. Furthermore, all radiology reporting is conducted through a sophisticated digital platform, which allows for rapid case reporting from any diagnostic centre, significantly reducing turnaround time and ensuring prompt medical intervention.
Suraksha Diagnostic Limited continues to innovate and expand its services, setting new benchmarks in the healthcare industry and reaffirming its commitment to excellence in patient care.
Suraksha Clinic and Diagnostic Limited IPO Overview:
- ● IPO Type: Book Built Issue
- ● Total Issue Size: ₹846.25 crores
- ● Offer Details: The IPO is entirely an Offer for Sale (OFS), with 1.92 crore shares being offered for sale by the existing shareholders.
- ● Price Band: ₹420 to ₹441 per share
- ● Minimum Lot Size: The minimum lot size for an application is 34 shares.
- ● Issue Opening Date: November 29, 2024
- ● Issue Closing Date: December 3, 2024
- ● Book Running Lead Managers: ICICI Securities Limited, Nuvama Wealth Management Limited, SBI Capital Markets Limited
- ● Registrar: Kfin Technologies Limited
WHAT IS GMP?
GMP (Grey Market Premium) is the difference between the IPO price and the grey market price. It is the premium amount paid for the traded IPO shares. It plays an important role in IPOs as it reflects how the IPO would react on the listing day.
A grey market is a place where shares/stocks are traded before being listed officially on the stock exchange.
Suraksha Clinic and Diagnostic Limited IPO GMP
| GMP Date | IPO Price | GMP | Last Updated |
|---|---|---|---|
| - | 441 | - | - |
**The GMP prices displayed here are solely for informational purposes related to the grey market news. India IPO does not engage in or facilitate grey market trading, nor are these rates (sub2) indicative of any trading activity. We also do not recommend or endorse participation in the grey market.**
Suraksha Clinic and Diagnostic Limited IPO Details
| Detail | Description |
|---|---|
| IPO Date | November 29, 2024 to December 3, 2024 |
| Listing Date | [.] |
| Face Value | ₹2 per share |
| Price Band | ₹420 to ₹441 per share |
| Lot Size | 34 Shares |
| Total Issue Size | 19,189,330 shares (aggregating up to ₹846.25 Cr) |
| Offer for Sale | 19,189,330 shares of ₹2 (aggregating up to ₹846.25 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Shareholding pre issue | 52,080,758 |
Suraksha Clinic and Diagnostic Limited IPO (Tentative Schedule)
| Detail | Description |
|---|---|
| IPO Open Date | Friday, November 29, 2024 |
| IPO Close Date | Tuesday, December 3, 2024 |
| Basis of Allotment | Wednesday, December 4, 2024 |
| Initiation of Refunds | Thursday, December 5, 2024 |
| Credit of Shares to Demat | Thursday, December 5, 2024 |
| Listing Date | Friday, December 6, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on December 3, 2024 |
Suraksha Clinic and Diagnostic Limited IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 34 | ₹14,994 |
| Retail (Max) | 13 | 442 | ₹194,922 |
| S-HNI (Min) | 14 | 476 | ₹209,916 |
| S-HNI (Max) | 66 | 2,244 | ₹989,604 |
| B-HNI (Min) | 67 | 2,278 | ₹1,004,598 |
Suraksha Clinic and Diagnostic Limited IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50% of the Net offer |
| Retail Shares Offered | Not less than 35% of the Net Offer |
| NII (HNI) Shares Offered | Not less than 15% of the Net Offer |
Suraksha Clinic and Diagnostic Limited IPO Promoter Holding
| Share Holding Pre Issue | 61.07% |
| Share Holding Post Issue | - |
Competitive Strengths are:
- ● Well-positioned diagnostics chain to capture the large growth opportunities for organized diagnostics chains in the fragmented markets for diagnostic services in eastern and northeastern India.
- ● Integrated diagnostics provider offering pathology and radiology testing and medical consultancy services from a single source.
- ● Well-invested and technologically advanced clinical infrastructure.
- ● Commitment to quality driving high individual consumer business share and customer retention.
- ● Management team with relevant industry experience.
Suraksha Clinic and Diagnostic Limited Financial Information
| Period Ended | 30 June 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | ||||||||||||||||||||||||||||||||||||
| Assets | 314.20 | 300.21 | 281.20 | 275.96 | ||||||||||||||||||||||||||||||||||||
| Revenue | 61.85 | 222.26 | 193.69 | 225.77 | ||||||||||||||||||||||||||||||||||||
| Profit After Tax | 7.67 | 23.13 | 6.07 | 20.82 | ||||||||||||||||||||||||||||||||||||
| Net Worth | 187.05 | 179.41 | 155.93 | 145.84 | ||||||||||||||||||||||||||||||||||||
| Reserves and Surplus | 176.80 | 170.88 | 147.40 | 137.31 | ||||||||||||||||||||||||||||||||||||
| Total Borrowing | 7.57 | 8.64 | 14.01 | 19.03 | ||||||||||||||||||||||||||||||||||||
| Amount in ₹ Crores | ||||||||||||||||||||||||||||||||||||||||
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 14.09% |
| ROCE | 21.46% |
| RoNW | 14.09% |
| Debt/Equity | 0.2 |
| P/BV | 13.1 |
| PAT Margin (%) | 10.57 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 4.44 | - |
| P/E (x) | 99.31 | - |
Suraksha Clinic and Diagnostic IPO Objective:
-
The Company will not receive any proceeds from the Offer for sale and all proceeds will go to the Selling Shareholders.
Suraksha Clinic and Diagnostic IPO FAQs
-
What is Suraksha Diagnostic IPO?
Suraksha Diagnostic IPO is a main-board IPO. The company is going to raise ₹846.25 Crores via IPO. The issue is priced at ₹420 to ₹441 per equity share. The IPO is to be listed on BSE & NSE.
-
When will the Suraksha Diagnostic IPO open for subscription?
The IPO is to open on November 29, 2024 for QIB, NII, and Retail Investors. The IPO will close on December 3, 2024.
-
What is Suraksha Diagnostic IPO Investors Portion?
The investors’ portion for QIB is 50%, NII is 15%, and Retail is 35%.
-
What is Suraksha Diagnostic IPO Issue Size?
Suraksha Diagnostic IPO issue size is ₹846.25 crores.
-
What is Suraksha Diagnostic IPO Price Band?
Suraksha Diagnostic IPO Price Band is ₹420 to ₹441.
-
What is Suraksha Diagnostic IPO Lot Size?
The minimum bid is 34 Shares with ₹14,994.
-
What is the Suraksha Diagnostic IPO Allotment Date?
Suraksha Diagnostic IPO allotment date is December 4, 2024.
-
What is the Suraksha Diagnostic IPO Listing Date?
Suraksha Diagnostic IPO listing date is December 6, 2024. The IPO is to be listed on BSE & NSE.
-
What is the Suraksha Diagnostic current GMP?
The current GMP of the Suraksha Diagnostic is ---.
RHP:
RHP of Suraksha Diagnostic Limited IPO
DRHP:
DRHP of Suraksha Diagnostic Limited IPO
Read More IPO related blogs- Ganesh Infraworld Limited IPO
_Limited_IPO_right.jpg)
_Limited_IPO_right.jpg)
_Mobility_&_Hospitality_Limited_IPO_right.jpg)
